Cambium Oncology LLC
Atlanta, GA Cambium Oncology LLC
- UEI
- FD2YFTNRQMK8
- CAGE
- 8C5G3
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- SAM.gov registration date
- Physical address
- 890 Los Angeles Ave NE, Atlanta, GA 30306, USA
- Website
- cambiumoncology.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a novel armored car-t immunotherapeutic for pancreatic cancer - pancreatic ductal adenocarcinoma (pdac)… | National Cancer Institute | $400,835 | |
| Development of a novel immunotherapeutic for acute myeloid leukemia - acute myeloid leukemia (AML) and the need for… | National Cancer Institute | $3,454,992 |
Quick answers
What is Cambium Oncology LLC's UEI?
Cambium Oncology LLC's Unique Entity ID (UEI) in SAM.gov is FD2YFTNRQMK8.
What is Cambium Oncology LLC's CAGE code?
Cambium Oncology LLC's CAGE code is 8C5G3.
Where is Cambium Oncology LLC located?
Cambium Oncology LLC's physical address in SAM.gov is 890 Los Angeles Ave NE, Atlanta, GA 30306, USA.
Is Cambium Oncology LLC registered in SAM.gov?
Yes. Cambium Oncology LLC's SAM.gov registration is active through June 2, 2027.
What is Cambium Oncology LLC's most recent federal award?
Cambium Oncology LLC's most recent federal grant award is Development of a novel armored car-t immunotherapeutic for pancreatic cancer - pancreatic ductal adenocarcinoma (pdac)… (R44CA298704), from National Cancer Institute, on May 1, 2025.
On GovTribe
See Cambium Oncology LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors